Jan 30, 2026
A Q4 beat quelled fears and highlighted strength in energy, margins and autonomy. With analysts lifting targets and shares already rising, Tesla looks positioned for further upside if execution holds.
Jan 29, 2026
Defensive European ADRs that sidestep U.S. tariff risk — three stocks with domestic revenue, steady dividends and structural tailwinds.
Jan 28, 2026
QCOM just exited extremely oversold RSI territory — the same setup that preceded a 70% rebound last time. With earnings looming and much of the downside priced in, the risk-reward looks tilted toward the bulls.
Jan 27, 2026
All eyes on Meta’s 2026 CapEx range and AI progress — a bigger-than-expected spending plan could pressure the stock, while positive updates on new models might restore investor confidence.
Jan 26, 2026
Piper Sandler argues hyperscaler network upgrades could spark renewed AI-driven demand for Arista, yet rich multiples and concentrated customers pose key risks. Upcoming earnings and capex signals will determine whether the “refresh” story translates into sustained growth.
Jan 25, 2026
Sentiment — not fundamentals — appears to be driving the sell-off, putting Abbott back in an attractive buy zone supported by accelerating earnings, wider margins and a long dividend track record. Still, watch key support levels — a deeper slide could leave room for more downside.
Jan 24, 2026
A modest Q4 beat and slower growth guidance sent shares tumbling as Netflix’s $82.7B all‐cash bid for Warner Bros. Discovery raises antitrust and financing concerns. Valuation sits near a two‐year low, leaving analysts torn between a rebound and continued downside.
Jan 21, 2026
Eli Lilly, Viking Therapeutics and Biogen each have near‐term catalysts — from GLP‐1 momentum to late‐stage neurodegenerative trials — that could drive big upside in 2026, even amid biotech's risks.
Jan 20, 2026
A rare sweet spot for investors: robust ~6.7% GDP growth, just 1.33% inflation and easing RBI policy are priming Indian banks and equities for a fresh leg up. From HDFC’s revival to the INDA ETF and China‐plus‐one inflows, here’s why global capital is rotating into India.
Jan 19, 2026
Turn market volatility into monthly, double-digit cash flow with option-overlay ETFs—SPYI, QQQI and JEPQ—designed to accelerate compounding through high payouts. Know the tradeoffs: capped upside, variable distributions and important tax differences before you invest.
Jan 18, 2026
Institutions are piling into calls ahead of February earnings, signaling big confidence in an impending upside. Momentum from new obesity and Parkinson’s drug prospects — plus a $100B U.S. investment pact — has traders positioning for a breakout.
Jan 17, 2026
Steady growth, tame inflation and falling rates are turning India into a magnet for global capital — and offering clear plays for investors.
